Ma, X.-Y.; Zhao, J.-F.; Ruan, Y.; Zhang, W.-M.; Zhang, L.-Q.; Cai, Z.-D.; Xu, H.-Q.
ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin. Molecules 2022, 27, 8790.
https://doi.org/10.3390/molecules27248790
AMA Style
Ma X-Y, Zhao J-F, Ruan Y, Zhang W-M, Zhang L-Q, Cai Z-D, Xu H-Q.
ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin. Molecules. 2022; 27(24):8790.
https://doi.org/10.3390/molecules27248790
Chicago/Turabian Style
Ma, Xiao-Yan, Jia-Fu Zhao, Yong Ruan, Wang-Ming Zhang, Lun-Qing Zhang, Zheng-Dong Cai, and Hou-Qiang Xu.
2022. "ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin" Molecules 27, no. 24: 8790.
https://doi.org/10.3390/molecules27248790
APA Style
Ma, X.-Y., Zhao, J.-F., Ruan, Y., Zhang, W.-M., Zhang, L.-Q., Cai, Z.-D., & Xu, H.-Q.
(2022). ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin. Molecules, 27(24), 8790.
https://doi.org/10.3390/molecules27248790